News + Filings Transactions
|
Klausner Richard
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/15/2023 | Lyell Immunopharma, Inc. | LYEL | Sale | Common Stock | 58k | $2.28 | $132.3k | Grantor | 08/15/2023 |
09/23/2022 | Lyell Immunopharma, Inc. | LYEL | Sale | Common Stock | 11.1k | $6.40 | $71k | Grantor | 09/23/2022 |
06/08/2022 | Lyell Immunopharma, Inc. | LYEL | Grant | Option (right to buy) | 65k | $5.31 | $345.2k | | 06/08/2021 |
06/21/2021 | Lyell Immunopharma, Inc. | LYEL | Conversion | Common Stock | 3.8M | $0.00 | $0 | Lyell Investors, LLC | 06/21/2021 |
06/21/2021 | Lyell Immunopharma, Inc. | LYEL | Conversion | Series A Convertible Preferred Stock | 3.8M | $0.00 | $0 | Lyell Investors, LLC | 06/21/2021 |
03/05/2018 | Juno Therapeutics, Inc. | JUNO | Disposition | Director Stock Option (Right to Buy) | 12k | $23.29 | $279.5k | | 03/05/2018 |
03/05/2018 | Juno Therapeutics, Inc. | JUNO | Disposition | Director Stock Option (Right to Buy) | 12k | $42.40 | $508.8k | | 03/05/2018 |
03/05/2018 | Juno Therapeutics, Inc. | JUNO | Disposition | Director Stock Option (Right to Buy) | 12k | $60.00 | $720k | | 03/05/2018 |
03/05/2018 | Juno Therapeutics, Inc. | JUNO | Other | Common Stock | 705.5k | $87.00 | $61.4M | | 03/05/2018 |
02/07/2018 | Juno Therapeutics, Inc. | JUNO | Gift | Common Stock | 23.2k | $0.00 | $0 | | 03/05/2018 |
01/08/2018 | Juno Therapeutics, Inc. | JUNO | Sale | Common Stock | 918 | $49.37 | $45.3k | | 01/05/2018 |
01/08/2018 | Juno Therapeutics, Inc. | JUNO | Sale | Common Stock | 4.8k | $48.95 | $237.2k | | 01/05/2018 |
01/08/2018 | Juno Therapeutics, Inc. | JUNO | Sale | Common Stock | 5k | $47.80 | $239.5k | | 01/05/2018 |
01/08/2018 | Juno Therapeutics, Inc. | JUNO | Sale | Common Stock | 1.9k | $46.85 | $91.3k | | 01/05/2018 |
01/05/2018 | Juno Therapeutics, Inc. | JUNO | Grant | Common Stock | 248 | $0.00 | $0 | | 01/05/2018 |
12/21/2017 | Juno Therapeutics, Inc. | JUNO | Sale | Common Stock | 32.9k | $44.72 | $1.5M | | 12/21/2017 |
12/21/2017 | Juno Therapeutics, Inc. | JUNO | Sale | Common Stock | 3.1k | $45.16 | $141.8k | | 12/21/2017 |
10/05/2017 | Juno Therapeutics, Inc. | JUNO | Grant | Common Stock | 266 | $0.00 | $0 | | 10/05/2017 |
09/07/2017 | Juno Therapeutics, Inc. | JUNO | Sale | Common Stock | 5.4k | $42.27 | $230.3k | | 09/07/2017 |
09/07/2017 | Juno Therapeutics, Inc. | JUNO | Sale | Common Stock | 5.2k | $42.76 | $222.9k | | 09/07/2017 |
09/07/2017 | Juno Therapeutics, Inc. | JUNO | Sale | Common Stock | 1.3k | $43.83 | $58.6k | | 09/07/2017 |
08/07/2017 | Juno Therapeutics, Inc. | JUNO | Sale | Common Stock | 12k | $30.34 | $364.1k | | 08/07/2017 |
07/07/2017 | Juno Therapeutics, Inc. | JUNO | Sale | Common Stock | 23.6k | $29.38 | $693.3k | | 07/05/2017 |
07/07/2017 | Juno Therapeutics, Inc. | JUNO | Sale | Common Stock | 400 | $30.00 | $12k | | 07/05/2017 |
07/05/2017 | Juno Therapeutics, Inc. | JUNO | Grant | Common Stock | 380 | $0.00 | $0 | | 07/05/2017 |
06/16/2017 | Juno Therapeutics, Inc. | JUNO | Grant | Stock Option (Right to Buy) | 12k | $23.29 | $279.5k | | 06/16/2017 |
06/07/2017 | Juno Therapeutics, Inc. | JUNO | Sale | Common Stock | 8.8k | $24.24 | $212.5k | | 06/07/2017 |
06/07/2017 | Juno Therapeutics, Inc. | JUNO | Sale | Common Stock | 15.2k | $23.23 | $353.8k | | 06/07/2017 |
04/05/2017 | Juno Therapeutics, Inc. | JUNO | Grant | Common Stock | 514 | $0.00 | $0 | | 04/05/2017 |
01/05/2017 | Juno Therapeutics, Inc. | JUNO | Grant | Common Stock | 591 | $0.00 | $0 | | 01/05/2017 |
10/05/2016 | Juno Therapeutics, Inc. | JUNO | Grant | Common Stock | 401 | $0.00 | $0 | | 10/05/2016 |
07/05/2016 | Juno Therapeutics, Inc. | JUNO | Grant | Common Stock | 300 | $0.00 | $0 | | 07/05/2016 |
06/24/2016 | Juno Therapeutics, Inc. | JUNO | Sale | Common Stock | 12k | $40.71 | $488.5k | | 06/24/2016 |
06/17/2016 | Juno Therapeutics, Inc. | JUNO | Grant | Stock Option (Right to Buy) | 12k | $42.40 | $508.8k | | 06/17/2016 |
05/18/2016 | Juno Therapeutics, Inc. | JUNO | Sale | Common Stock | 12k | $40.00 | $480k | | 05/18/2016 |
|
|